Carlos Salama discusses how hospitalized patients with Covid-19 pneumonia who were not receiving mechanical ventilation and received tocilizumab showed a reduction in the likelihood of progression to the composite outcome of mechanical ventilation or death, but it did not improve survival.
Image courtesy of Carlos Salama
Image courtesy of interviewee
